Alyiah Karmali on Muck Rack

Alyiah Karmali

As seen in: Science Magazine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Alyiah

Contact Alyiah, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

EGFR inhibition down-regulates MGMT and enhances responsiveness to temozolomide in glioblastoma

|
By Xiwei Zhang, Camille Vaganay, Arifa Nayab, Nouman Mughal, Meher Angez, Aarohan Burma, Harshitha Balla, Sani H. Kizilbash, Fazal Arain, Azhar Hussain, Deepti Singh, Ankur Patel, Kimmo J. Hatanpaa, Michael Youssef, Nawal Shaikh, Sandeep Burma, Jann N. Sarkaria, Sansi Xing, Xiaoyao Yang, Muhammad Asad Maqbool, Sahara Amir, Alyiah Karmali, Saif Somani, Carissa Ye, Dawen Zhao
| Science Magazine Verified
Editor’s summary Abstract Supplementary Materials REFERENCES AND NOTES Information & Authors Metrics & Citations Check Access References Figures Tables Media Share Editor’s summary Current treatment for glioblastoma (GBM) includes temozolomide (TMZ), which is more effective when the promoter of O6 methylguanine DNA methyltransferase (MGMT) is methylated and MGMT expression is repressed. Here, Nayab et al.
Open in Who Shared Issue with article?
See all 1 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified